Enter assignee name

Trademarks = 1

Forward Citations = 5

Loading Chart...

10 inventors (with patents filed for the assignee):

Sophie Cazanave (4 out of 5 patents)

Sangeeta N Bhatia (2 out of 60 patents)

Sirshendu Roopom Banerjee (2 out of 3 patents)

4. Eric Huang (2 out of 2 patents)

5. Andrew Warren (2 out of 8 patents)

6. Gabriel A Kwong (2 out of 15 patents)

7. Mehar Cheema (2 out of 3 patents)

8. Wendy Winckler Adamovich (2 out of 4 patents)

9. Faycal Touti (2 out of 3 patents)

10. Robert Samuel Langer (2 out of 621 patents)

4 patents: Sort by Forward Citations

1. 11851697 - Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment (2023-12-26),

2. 11732009 - Activity sensor with tunable analyte (2023-08-22),

3. 11604193 - Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment (2023-03-14),

4. 11028425 - Diagnosis and monitoring of liver disease (2021-06-08),

Glympse Bio, Inc. is a biotechnology company focused on developing non-invasive diagnostic technologies for various diseases. They specialize in utilizing proprietary nanoparticle technology to detect and monitor biomarkers in the body, enabling early disease detection and personalized treatment. The company's innovative approach has the potential to revolutionize healthcare by providing more accurate and timely diagnostic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#378 in Cambridge, MA

#3,235 in Massachusetts

#59,059 in US

Cambridge, MA, United States of America

Glympse Bio, Inc.